Tablet Splitting Yields Unpredictable Response

Susan Farley
Published Online: Wednesday, December 1, 2004

Researchers from Rutgers University set out to determine the effects when patients try to halve their doses of unscored tablets. They found that the drugs ended up differing in weight and content, thus resulting in unpredictable dosing and therapeutic response. Cyclobenzaprine hydrochloride in 10-mg tablets was used in the study; these tablets are round, film-coated, and unscored. Before splitting, the mean weight of 45 tablets was 136.6 mg +/- 2.1 mg, yielding a theoretical weight of 68.3 mg per perfectly split tablet.

The fragment weights were measured at 67.9 mg +/- 7.9 mg. The resulting weights proved that the tablet fragments, after splitting, yielded a significant difference in weight and estimated drug content. Therefore, in this particular study, dividing a 10-mg tablet of cyclobenzaprine in order to get a 5-mg dose could result in an uncertain dose level and an equally uncertain therapeutic response.

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues